• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Lundbeckfond Ventures

edit

Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an open evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, Lundbeckfond Ventures invests up to € 50 million but will from time to time engage in larger investments through additional financial resources from the Lundbeck Foundation.

Recent Milestones

edit

• 
  Lundbeckfond Ventures invested in DySISmedical. (4/15/13)
  Posted 4/16/13 at 4:17am via finsmes.com
• 
  Lundbeckfond Ventures invested in River Vision Development. (12/12/12)
  Posted 12/13/12 at 2:38am via prnewswire.com
• 
  Lundbeckfond Ventures invested in BONESUPPORT. (6/19/12)
  Posted 6/19/12 at 6:13pm via finsmes.com
• 
  Lundbeckfond Ventures invested in Enterome. (3/23/12)
  Posted 3/23/12 at 6:11pm via finsmes.com
• 
  Lundbeckfond Ventures invested in Celladon. (2/15/12)
  Posted 2/15/12 at 6:31pm via finsmes.com
• 
  Lundbeckfond Ventures invested in Acacia Pharma. (3/31/11)
  Posted 3/31/11 at 6:15pm via acaciapharma.com
• 
  Lundbeckfond Ventures invested in Nexstim. (1/26/11)
  Posted 1/27/11 at 4:27am via tmcnet.com
• 
  Lundbeckfond Ventures invested in Syntaxin. (11/11/10)
  Posted 11/11/10 at 6:27pm via fiercebiotech.com

Investments

Videos

Sources

1. DySIS Medical Completes £7.4M Funding (finsmes.com) [edit]
2. River Vision Announces Completion of $17 million Series A Financing (m.prnewswire.com) [edit]
3. BONESUPPORT Raises SEK70M in Funding (finsmes.com) [edit]
4. Enterome Raises €5M in Series A Funding (finsmes.com) [edit]
5. Celladon Closes $43M in Funding (finsmes.com) [edit]
6. Acacia Pharma Closes $10 Million Investment Round (acaciapharma.com) [edit]
7. Nexstim, a Medical Device Company, Raises over EUR 11 Million in New Equity Financing (tmcnet.com) [edit]
8. VCs inject $29M into Syntaxin, $11.5M into Ceregene (fiercebiotech.com) [edit]